Cao, Y., Ruan, M., Wang, S., Liu, J., Zhao, Q., Tang, X., Ma, J., Lin, C., Du, P. (2026). Real-world effectiveness of disitamab vedotin plus PD-1 inhibitor versus platinum-based chemotherapy as postoperative adjuvant therapy in high-risk upper tract urothelial carcinoma: A comparative study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4611